Front Immunol. 2012 Jul 23;3:213. doi: 10.3389/fimmu.2012.00213. eCollection 2012.
Antimicrobial activities of chemokines: not just a side-effect?.
Frontiers in immunology
Marlene Wolf, Bernhard Moser
Affiliations
Affiliations
- Theodor Kocher Institute, University of Bern Bern, Switzerland.
PMID: 22837760
PMCID: PMC3401835 DOI: 10.3389/fimmu.2012.00213
Abstract
The large family of chemoattractant cytokines (chemokines) embraces multiple, in part unrelated functions that go well beyond chemotaxis. Undoubtedly, the control of immune cell migration (chemotaxis) is the single, unifying response mediated by all chemokines, which involves the sequential engagement of chemokine receptors on migrating target cells. However, numerous additional cellular responses are mediated by some (but not all) chemokines, including angiogenesis, tumor cell growth, T-cell co-stimulation, and control of HIV-1 infection. The recently described antimicrobial activity of several chemokines is of particular interest because antimicrobial peptides are thought to provide an essential first-line defense against invading microbes at the extremely large body surfaces of the skin, lungs, and gastrointestinal-urinary tract. Here we summarize the current knowledge about chemokines with antimicrobial activity and discuss their potential contribution to the control of bacterial infections that may take place at the earliest stage of antimicrobial immunity. In the case of homeostatic chemokines with antimicrobial function, such as CXCL14, we propose an immune surveillance function in healthy epithelial tissues characterized by low-level exposure to environmental microbes. Inflammatory chemokines, i.e., chemokines that are produced in tissue cells in response to microbial antigens (such as pathogen-associated molecular patterns) may be more important in orchestrating the cellular arm in antimicrobial immunity.
Keywords: antimicrobial immunity; antimicrobial peptides; chemokines; immune surveillance
References
- J Exp Med. 2000 Oct 2;192(7):1069-74 - PubMed
- Science. 1963 Nov 22;142(3595):1085-7 - PubMed
- Trends Immunol. 2009 Mar;30(3):131-41 - PubMed
- J Leukoc Biol. 2000 Jul;68(1):9-14 - PubMed
- J Invest Dermatol. 2003 Mar;120(3):379-89 - PubMed
- J Biol Chem. 1996 Feb 9;271(6):2935-40 - PubMed
- Cell Mol Life Sci. 2003 Apr;60(4):711-20 - PubMed
- J Biol Chem. 2000 Jul 7;275(27):20374-81 - PubMed
- J Immunol. 2006 Jul 15;177(2):782-6 - PubMed
- Exp Dermatol. 2008 Aug;17(8):633-9 - PubMed
- J Invest Dermatol. 2010 Dec;130(12):2836-8 - PubMed
- J Allergy Clin Immunol. 2009 Sep;124(3 Suppl 2):R13-8 - PubMed
- Antimicrob Agents Chemother. 2008 Mar;52(3):883-94 - PubMed
- Trends Immunol. 2004 Feb;25(2):75-84 - PubMed
- J Invest Dermatol. 2007 Mar;127(3):594-604 - PubMed
- Biotechnol Lett. 2005 Sep;27(18):1337-47 - PubMed
- J Immunol. 2003 Feb 1;170(3):1452-61 - PubMed
- Neurosci Lett. 2011 Jan 10;487(3):335-40 - PubMed
- Immunology. 2002 May;106(1):20-6 - PubMed
- PLoS One. 2009 Jul 28;4(7):e6395 - PubMed
- Eur J Immunol. 2007 Sep;37(9):2474-86 - PubMed
- J Biol Chem. 2011 Jan 28;286(4):2469-76 - PubMed
- Nat Med. 2006 Jun;12(6):636-41 - PubMed
- Eur J Immunol. 2010 Jan;40(1):186-96 - PubMed
- J Allergy Clin Immunol. 2003 Dec;112(6):1195-202 - PubMed
- Mucosal Immunol. 2010 Jan;3(1):40-8 - PubMed
- J Invest Dermatol. 2009 Sep;129(9):2091-3 - PubMed
- J Biol Chem. 2002 Oct 4;277(40):37647-54 - PubMed
- J Allergy Clin Immunol. 2007 Feb;119(2):457-63 - PubMed
- Biochem Biophys Res Commun. 2007 Apr 6;355(2):352-8 - PubMed
- FEBS J. 2011 Oct;278(20):3942-51 - PubMed
- J Immunol. 2004 Mar 1;172(5):3070-7 - PubMed
- Biochem Biophys Res Commun. 2006 Sep 22;348(2):406-12 - PubMed
- Nature. 2011 Jan 20;469(7330):419-23 - PubMed
- Endocrinology. 2009 Dec;150(12):5596-605 - PubMed
- J Biol Chem. 1997 Jun 13;272(24):15258-63 - PubMed
- PLoS Pathog. 2010 Nov 18;6(11):e1001199 - PubMed
- Pediatr Res. 2003 Apr;53(4):566-72 - PubMed
- J Immunol. 2011 Oct 15;187(8):4300-9 - PubMed
- J Leukoc Biol. 2004 Jan;75(1):39-48 - PubMed
- J Exp Med. 2001 Sep 17;194(6):855-61 - PubMed
- Cancer Lett. 2008 Feb 8;259(2):209-17 - PubMed
- Science. 1999 Oct 15;286(5439):525-8 - PubMed
- J Immunol. 2001 Jul 15;167(2):623-7 - PubMed
- Antimicrob Agents Chemother. 2005 Sep;49(9):3889-95 - PubMed
- Cancer Res. 2004 Nov 15;64(22):8262-70 - PubMed
- Biochim Biophys Acta. 2010 Jun;1798(6):1062-72 - PubMed
- J Biol Chem. 2002 Nov 29;277(48):46779-84 - PubMed
- Infect Immun. 2000 May;68(5):2748-55 - PubMed
- J Neurochem. 2011 Dec;119(6):1173-82 - PubMed
- Int Immunol. 2000 May;12(5):677-89 - PubMed
- Antimicrob Agents Chemother. 2003 Sep;47(9):2804-9 - PubMed
- J Leukoc Biol. 2003 Sep;74(3):448-55 - PubMed
- Cancer Res. 2009 Mar 15;69(6):2375-83 - PubMed
- J Immunol. 2006 Jun 1;176(11):6512-22 - PubMed
- J Immunol. 2004 Jan 15;172(2):1146-56 - PubMed
- Mol Cell Biol. 2007 Feb;27(3):983-92 - PubMed
- J Immunol. 2007 Sep 15;179(6):3958-65 - PubMed
- Antimicrob Agents Chemother. 2008 Jul;52(7):2599-607 - PubMed
- J Infect Dis. 2007 Mar 1;195(5):684-93 - PubMed
- PLoS One. 2010 Apr 23;5(4):e10321 - PubMed
- Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3414-9 - PubMed
- Crit Rev Immunol. 2008;28(3):185-200 - PubMed
- J Biol Chem. 1994 Jun 10;269(23):16075-81 - PubMed
- Blood. 2000 Nov 1;96(9):3086-93 - PubMed
- Nat Rev Microbiol. 2005 Mar;3(3):238-50 - PubMed
- Blood. 2001 Jun 15;97(12):3951-9 - PubMed
- Biochem Biophys Res Commun. 2010 Jun 11;396(4):1060-4 - PubMed
- J Clin Invest. 1989 Dec;84(6):2017-20 - PubMed
- Virulence. 2010 Sep-Oct;1(5):440-64 - PubMed
- J Am Acad Dermatol. 2005 Mar;52(3 Pt 1):381-90; quiz 391-2 - PubMed
- Infect Immun. 2002 Jun;70(6):3053-60 - PubMed
- J Reprod Immunol. 2008 Oct;79(1):37-43 - PubMed
- Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1885-90 - PubMed
- Infect Immun. 2009 Apr;77(4):1664-78 - PubMed
- Nat Immunol. 2005 Jan;6(1):57-64 - PubMed
- PLoS One. 2009;4(3):e4769 - PubMed
- Nat Immunol. 2001 Dec;2(12):1133-7 - PubMed
- Oncogene. 2008 Nov 20;27(54):6856-65 - PubMed
- N Engl J Med. 2002 Oct 10;347(15):1151-60 - PubMed
- Cell. 1997 Feb 21;88(4):553-60 - PubMed
- Proc Natl Acad Sci U S A. 2003 Jul 22;100(15):8880-5 - PubMed
- Nature. 2002 Jan 24;415(6870):389-95 - PubMed
- J Immunol. 2005 May 1;174(9):5490-8 - PubMed
- J Biol Chem. 2007 Oct 19;282(42):30794-803 - PubMed
- Science. 2006 Mar 24;311(5768):1770-3 - PubMed
- EMBO J. 2006 Nov 29;25(23):5569-78 - PubMed
- Nature. 2001 Nov 22;414(6862):454-7 - PubMed
- Biochem Biophys Res Commun. 1999 Feb 24;255(3):703-6 - PubMed
- J Neurochem. 2009 May;109 Suppl 1:117-25 - PubMed
- Am J Pathol. 2000 Jun;156(6):1937-50 - PubMed
- Nat Rev Microbiol. 2004 Sep;2(9):727-38 - PubMed
- Immunity. 2005 Sep;23(3):331-42 - PubMed
- J Immunol. 2009 Jan 1;182(1):507-14 - PubMed
- Infect Immun. 2002 Jun;70(6):3068-72 - PubMed
- FASEB J. 2006 Oct;20(12):2068-80 - PubMed
- Nat Rev Immunol. 2003 Sep;3(9):710-20 - PubMed
- Blood. 2009 Jun 4;113(23):5848-56 - PubMed
- Cell Mol Life Sci. 2008 Oct;65(19):3019-27 - PubMed
- Cytokine. 2008 Nov;44(2):248-55 - PubMed
Publication Types